Gastrointestinal manifestations in COVID-19
JC Kariyawasam, U Jayarajah, R Riza… - Transactions of The …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19), a respiratory viral infection, has affected
more than 78 million individuals worldwide as of the end of December 2020. Previous …
more than 78 million individuals worldwide as of the end of December 2020. Previous …
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …
virus can lead to serious systemic consequences affecting major organs including the …
Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study
Objective To evaluate the relation between intake of ultra-processed food and risk of
inflammatory bowel disease (IBD). Design Prospective cohort study. Setting 21 low, middle …
inflammatory bowel disease (IBD). Design Prospective cohort study. Setting 21 low, middle …
[HTML][HTML] Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020
ВБ Гриневич, ИВ Губонина, ВЛ Дощицин… - Кардиоваскулярная …, 2020 - cyberleninka.ru
Пандемия новой коронавирусной инфекции (COVID19), распространяемая вирусом
SARS-CoV-2, стала вызовом системам здравоохранения всех стран мира …
SARS-CoV-2, стала вызовом системам здравоохранения всех стран мира …
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical …
SARS-CoV-2 has caused a global health crisis and mass vaccination programmes provide
the best opportunity for controlling transmission and protecting populations. Despite the …
the best opportunity for controlling transmission and protecting populations. Despite the …
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
The COVID-19 pandemic has led to an exponential increase in SARS-CoV-2 infections and
associated deaths, and represents a significant challenge to healthcare professionals and …
associated deaths, and represents a significant challenge to healthcare professionals and …
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
NA Kennedy, JR Goodhand, C Bewshea, R Nice… - Gut, 2021 - gut.bmj.com
Objective Antitumour necrosis factor (anti-TNF) drugs impair protective immunity following
pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious …
pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious …
Inflammatory bowel disease management during the COVID-19 outbreak: the ten do's and don'ts from the ECCO-COVID taskforce
Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and
recommendations, almost on a daily basis. It behooves the medical community to provide …
recommendations, almost on a daily basis. It behooves the medical community to provide …
Calprotectin in inflammatory bowel disease
The term IBD is usually used for referring to a group of inflammatory gastro-intestinal
diseases (mainly Crohn's disease and ulcerative colitis). Accordingly, IBD arises as a result …
diseases (mainly Crohn's disease and ulcerative colitis). Accordingly, IBD arises as a result …
Administration of COVID-19 vaccines in immunocompromised patients
Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …
several populations such as patients with specific immunological conditions have been …